Fig. 6.
American College of Rheumatology 20 (ACR20) response over 52 weeks in a patients initially randomized to apremilast 20 mg twice daily (BID) and b patients initially randomized to apremilast 30 mg BID (data as observed). PALACE Psoriatic Arthritis Long-term Assessment of Clinical Efficacy. Reproduced with permission from Blanco et al. [33]
